Company Overview of NanoBio Corporation
NanoBio Corporation, a biopharmaceutical company, focused on developing and commercializing intranasal and intramuscular vaccines. The company offers vaccines targeting respiratory, sexually transmitted, and other diseases. It offers NanoStat Platform that utilizes a novel oil-in-water emulsion adjuvant to enable vaccines that elicit broad protection against disease. The company’s lead product candidates include vaccines for RSV, herpes simplex virus-2, H5 influenza, human immunodeficiency virus, seasonal and pandemic influenza, pertussis, and anthrax. It has a strategic alliance with Merck & Co., Inc. NanoBio Corporation was founded in 1999 and is based in Ann Arbor, Michigan.
2311 Green Road
Ann Arbor, MI 48105
Founded in 1999
Key Executives for NanoBio Corporation
NanoBio Corporation Key Developments
Similar Private Companies By Industry
|Enzo Therapeutics, Inc.||United States|
|MediQuest Therapeutics, Inc.||United States|
|Advanced Bio-Technologies, Inc.||United States|
|Purdue Pharma Technologies Inc.||United States|
|Attenuon, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact NanoBio Corporation, please visit www.nanobio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.